Journal profile · Neurosciences
NeuroMolecular Medicine
ISSN 1535-1084 · eISSN 1559-1174 · Springer US · UNITED STATES · Quarterly · Founded 2002
NeuroMolecular Medicine: CAS Zone 4 · Medicine (2025 upgraded edition); impact factor 3.83; hybrid open access; APC about USD 4,990; median 70 days to acceptance (99 articles, last 24 months); community-reported acceptance: moderate; 76 articles in 2025; indexed in SCIE and Scopus.
Scope
Aims, scope and focus
NeuroMolecular Medicine is published by Springer US and is in Zone 4 of Medicine in the CAS Journal Ranking (2025 upgraded edition). By OpenAlex counts of its recent articles, its largest topics are Neuroinflammation and Neurodegeneration Mechanisms, Alzheimer's disease research and treatments and Mitochondrial Function and Pathology, together about 28.8% of its articles. Its main subfields are Cellular and Molecular Neuroscience. (generated from OpenAlex topic counts and CAS ranking data)
NeuroMolecular Medicine publishes research on the genetic, molecular and biochemical basis of a wide array of neurological disorders. We will only consider studies that include mechanistic insights, and in-vivo studies must accompany in-vitro analyses, to provide relevance to disease models.
From the journal's Aims & Scope
Research area (LetPub): Neurosciences
Editor-in-chief Eitan OkunPublisher website
Editorial board by country: none in mainland China; most named Singapore 3, United States 2, Taiwan, China 1, Germany 1 (7 members with a country) Editorial board ↗Publisher website ·
Main research topics OpenAlex counts of recent articles; shares are approximate
- Neuroinflammation and Neurodegeneration MechanismsNeuroscience11.6%
- Alzheimer's disease research and treatmentsMedicine10.8%
- Mitochondrial Function and PathologyBiochemistry, Genetics and Molecular Biology6.5%
- Neuroscience and Neuropharmacology ResearchNeuroscience6.4%
- Parkinson's Disease Mechanisms and TreatmentsMedicine5.8%
- Neurogenesis and neuroplasticity mechanismsNeuroscience4.5%
- MicroRNA in disease regulationBiochemistry, Genetics and Molecular Biology4.4%
- Nerve injury and regenerationNeuroscience4.4%
Rankings & indexing
CAS ranking and database indexing
CAS Journal Ranking
CAS Journal Ranking, upgraded edition (March 2025)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: no
CAS Xinrui Journal Ranking (March 2026)Medicine Zone 3
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 3 |
| Minor | Neurosciences | Zone 3 |
Top journal: noReview journal: not marked
CAS Journal Ranking, previous upgraded edition (December 2023)Medicine Zone 4
| Level | Category | Zone |
|---|---|---|
| Major | Medicine | Zone 4 |
| Minor | Neurosciences | Zone 4 |
Top journal: noReview journal: no
Database indexing
SCIEScopusLetPub
International journal early-warning lists: not listed in any editionLetPub
Indexing the journal's website claims
MEDLINEEmbaseCASPublisher website
Other: Google Scholar, EBSCO, ProQuest, Dimensions, CNKI, Baidu, Naver, OCLC, Portico, CLOCKSS
As the journal's website lists them, not checked against each database; for Web of Science editions the records above apply.
Editions, and major and minor categories, are shown separately and never merged into one zone; check which edition your institution uses before you submit or report.
Metrics
Impact metrics and publication volume
Impact
- Impact factor
- 3.83LetPub ·
- Impact factor (publisher) 2025
- 3.8Publisher website ·
- 5-year impact factor (publisher) 2025
- 3.7Publisher website ·
- CiteScore 2026-06
- 6LetPub ·
- SJR 2026-06
- 0.98LetPub ·
- SNIP 2026-06
- 0.69LetPub ·
- h-index
- 66LetPub ·
- h-index
- 100OpenAlex ·
- i10-index
- 798OpenAlex ·
- 2-year mean citedness
- 3.95OpenAlex ·
- Self-citation rate
- 0%LetPub ·
- Share of gold OA articles
- 27.16%LetPub ·
Volume
- Articles per year
- 76LetPub ·
- Downloads per year (publisher) 2025
- 307,900Publisher website ·
Articles by year OpenAlex count · 1,141 in total · the current year is incomplete
| Year | Articles | Open access | Citations |
|---|---|---|---|
| 2026 | 50 | 14 | 29 |
| 2025 | 76 | 24 | 333 |
| 2024 | 54 | 14 | 349 |
| 2023 | 34 | 12 | 424 |
| 2022 | 35 | 13 | 624 |
| 2021 | 62 | 19 | 1,062 |
Sources count differently and were observed at different times, so each source's own value is kept; "publisher" marks figures from the journal's website.
Review & acceptance
Review time and acceptance
Review time from article dates manuscript dates registered with Crossref · to
70 daysMedian, submission to acceptance · P25–P75 51 days – 105 days
- Acceptance to online
- median 16 days (99 articles)
- Submission to online
- median 92 days
- Sample
- 99 articles with submission and acceptance dates (141 in the window); the latest was accepted on
Only articles that were accepted and published are counted, not the time spent on rejected manuscripts, so this usually runs longer than a publisher's "time to first decision".
Other sources
- Average review time (community reports)
- over 12 weeksLetPub ·
- Average acceptance (community reports)
- ModerateLetPub ·
- Submission to first decision
- 2 daysPublisher website ·
- Peer review
- Double anonymous peer reviewPublisher website
Community reports come from authors' own submissions (confidence 0.5) and are not a promise from the journal; for publisher figures, the journal's own definitions apply.
Fees & open access
APC and open-access policy
Hybrid open accessLetPub
A subscription journal in which authors can pay to publish their article open access.
| Source | APC | Fee waiver | License | Observed |
|---|---|---|---|---|
| OpenAlex | USD 4,990 / EUR 3,890 / GBP 3,090 | — | — |
A hybrid journal charges the APC only when the author chooses open access; publishing under the subscription model is usually free.
The journal's website is authoritative for fees; sources were observed at different times and each keeps its own value, without averaging.
Submission
Article types and submission policies (journal website)
What to prepare7 items from the author guidelines
- Abstract
- 150–250 words
- Keywords
- ≥ 4
- Manuscript length
- ≤ 6,000 words
- Reference style
- APA
- First submission
- Free format: the journal's layout is not required
- Suggested reviewers
- Optional
- Cover letter
- Required
Article types accepted11, with length limits
- commentary articlesCommentary Articles: Commentary articles are short, narrowly focused articles that are commissioned by the journal. Commentary articles seek to provide a critic…Length not stated
- full length reviewsFull length Reviews: Reviews are comprehensive analyses of specific topics relevant to mechanistic understanding or therapeutic development of a CNS condition. …Length not stated
- letterOriginal Articles: Full-length reports of current research. Abstract: 250 words maximum. Introduction: 500 words max; Discussion: 1,500 words max. Article: 6,00…Length not stated
- meeting reportMeeting Report: By invitation only. An account of proceedings at recent a recent conference of broad interest to the target readership of the journal.Length not stated
- mini-reviewsMini-reviews: Maximum length of 2,000 words excluding Title page, References and acknowledgments. Can have 2 cartoons or figures. Abstract maximum length of 150…Length not stated
- nano-reviewsNano-reviews: Maximum length of 1,000 words excluding Title page, References and acknowledgments. Can have 1 cartoon or figure. Abstract maximum length of 100 w…Length not stated
- original articleOriginal Articles: Full-length reports of current research. Abstract: 250 words maximum. Introduction: 500 words max; Discussion: 1,500 words max. Article: 6,00…main text ≤ 250 words · abstract ≤ 250 words · references ≤ 40
- rapid communicationOriginal Articles: Full-length reports of current research. Abstract: 250 words maximum. Introduction: 500 words max; Discussion: 1,500 words max. Article: 6,00…main text ≤ 1,500 words · references ≤ 15
- reviewOriginal Articles: Full-length reports of current research. Abstract: 250 words maximum. Introduction: 500 words max; Discussion: 1,500 words max. Article: 6,00…main text ≤ 2,000 words
- review articleOriginal Articles: Full-length reports of current research. Abstract: 250 words maximum. Introduction: 500 words max; Discussion: 1,500 words max. Article: 6,00…Length not stated
- review articlesReview Articles: Usually by invitation only. Authors are required to submit a 1-page pre-submission inquiry to the Editors in-chief: Raghu Vemuganti (vemuganti@…Length not stated
Policy excerpts from the journal's websiteAI use, Authorship, Conflicts of interest, Data availability, Publication ethics, License & copyright, Open access, Trial registration / reporting guidelines
- AI use Generative AI Images
LLMs cannot be authors Model summary
Please check Springer’s policy on generative AI images and make sure your work adheres to the principles described therein. Back to top
Source ↗Publisher website ·- Authorship Authorship principles
Originality and exclusivity of submissions required Model summary
These guidelines describe authorship principles and good authorship practices to which prospective authors should adhere to. Authorship clarified The Journal and Publisher assume all authors agreed with the content and that all gave explicit consent to submit and that they obtained consent from the responsible authorities at the institute/organization where the work has been carried out, before th…
Source ↗Publisher website ·- Conflicts of interest Disclosures and declarations
All authors are requested to include information regarding sources of funding, financial or non-financial interests, study-specific approval by the appropriate ethics committee for research involving humans and/or animals, informed consent if the research involved human participants, and a statement on welfare of animals if the research involved animals (as appropriate). The decision whether such …
Source ↗Publisher website ·- Data availability Data availability statements
All original research must include a data availability statement. This statement should explain how to access data supporting the results and analysis in the article, including links/citations to publicly archived datasets analysed or generated during the study. Please see our full policy here. If it is not possible to share research data publicly, for instance when individual privacy could be com…
Source ↗Publisher website ·- Publication ethics Compliance with Ethical Standards
COPE member journal Model summary
To ensure objectivity and transparency in research and to ensure that accepted principles of ethical and professional conduct have been followed, authors should include information regarding sources of funding, potential conflicts of interest (financial or non-financial), informed consent if the research involved human participants, and a statement on welfare of animals if the research involved an…
Source ↗Publisher website ·- License & copyright Copyright
Permissions required for previously published material Model summary
Open Choice articles do not require transfer of copyright as the copyright remains with the author. In opting for open access, the author(s) agree to publish the article under a Creative Commons license. Details of the OA licences offered to authors can be found on the individual journal website, in the journal's How to publish with us guide. Back to top
Source ↗Publisher website ·- Open access Open access publishing
To find out more about publishing your work Open Access in NeuroMolecular Medicine, including information on fees, funding and licences, visit our Open access publishing page. Back to top
Source ↗Publisher website ·- Trial registration / reporting guidelines Clinical Trial Registration
The World Health Organization (WHO) definition of a clinical trial is "any research study that prospectively assigns human participants or groups of humans to one or more health-related interventions to evaluate the effects on health outcomes". The WHO defines health interventions as “A health intervention is an act performed for, with or on behalf of a person or population whose purpose is to ass…
Source ↗Publisher website ·
Excerpts are quoted from the journal's website; "model summary" lines are written by Workers AI and checked against the text. The journal's website is authoritative.
Profile
Publication details and official links
- Publisher
- Springer US
- Country or region
- UNITED STATES
- Language
- English
- Frequency
- Quarterly
- Founded
- 2002
- ISSN
- 1535-1084
- Electronic ISSN
- 1559-1174
- Official links
- Journal homepage ↗OpenAlex
- Submission system ↗LetPub
- Author guidelines ↗LetPub
FAQ
Frequently asked questions about NeuroMolecular Medicine
What CAS zone is NeuroMolecular Medicine in?
In the 2025 upgraded edition of the CAS Journal Ranking, NeuroMolecular Medicine is in Zone 4 of Medicine, and in Zone 4 of the minor category Neurosciences. In the 2026 Xinrui edition it is in Zone 3 of Medicine. Zones from different editions, and from major and minor categories, are not interchangeable.
What is the impact factor of NeuroMolecular Medicine?
The latest impact factor listed by LetPub is 3.83; CiteScore 6, h-index 100.
How long does peer review take at NeuroMolecular Medicine?
Based on the dates recorded on 99 articles published between October 2024 and October 2026 (the last 24 months), the median time from submission to acceptance is 70 days (interquartile range 51–105 days); authors report an average review time of over 12 weeks; the community-reported acceptance is “Moderate”. Article statistics cover accepted papers only, publisher figures follow the journal's own definitions, and community reports come from authors' own submissions; none is a promise from the journal.
What are the manuscript requirements of NeuroMolecular Medicine?
According to the journal's author guidelines: Abstract: 150–250 words; Keywords: ≥ 4; Manuscript length: ≤ 6,000 words; Reference style: APA; First submission: Free format: the journal's layout is not required; Suggested reviewers: Optional; Cover letter: Required. A model extracted these from the author guidelines and each was checked against the text; check the latest version on the journal's website before submitting.
Where are the editorial board members of NeuroMolecular Medicine based?
Of the 7 board members whose country the journal's board page names, none are in mainland China; the countries named most often are Singapore (3), United States (2) and Taiwan, China (1). Counted from the institutions listed on the board page; for reference only.
Which databases index NeuroMolecular Medicine?
According to LetPub and DOAJ records, NeuroMolecular Medicine is indexed in SCIE and Scopus. The journal's website also lists MEDLINE, Embase and CAS; that list has not been checked against each database.
Is NeuroMolecular Medicine open access, and what is the APC?
NeuroMolecular Medicine is a hybrid journal. For open-access publication: APC about USD 4,990.
Sources and updates
The facts on this page come from LetPub, OpenAlex, Publisher website; every figure is tagged with its source and the date it was observed, and conflicting values are kept per source. LetPub source page: view ↗ (archived 2026-08-26). Last updated: .